Split History
ETFs Holding OMED »    OMED Historical Stock Prices »



Video: What is a Stock Split?


If the video does not load after a few moments, Upgrade to the Latest Flash Player.
OncoMed Pharmaceuticals is a clinical-stage biopharmaceutical company. Co. has four anti-cancer therapeutic candidates: Navicixizumab, which is a bispecific monoclonal antibody that targets and inhibits both Delta-like ligand 4, and vascular endothelial growth factor; Anti-TIGIT, which is an inhibitory receptor that stops T-cells from attacking certain tumor cells; GITRL-Fc, which is engineered using a single-gene, linkerless trimer technology that is designed to enable activation of glucocorticoid-induced tumor necrosis factor receptor-related protein; and Rosmantuzumab, which is a monoclonal antibody targeting the RSPO-LGR cancer stem cell pathway. According to our OMED split history records, OMED has had 1 split.
OMED split history picture
OMED (OMED) has 1 split in our OMED split history database. The split for OMED took place on August 16, 1999. This was a 1 for 5 reverse split, meaning for each 5 shares of OMED owned pre-split, the shareholder now owned 1 share. For example, a 1000 share position pre-split, became a 200 share position following the split.

When a company such as OMED conducts a reverse share split, it is usually because shares have fallen to a lower per-share pricepoint than the company would like. This can be important because, for example, certain types of mutual funds might have a limit governing which stocks they may buy, based upon per-share price. The $5 and $10 pricepoints tend to be important in this regard. Stock exchanges also tend to look at per-share price, setting a lower limit for listing eligibility. So when a company does a reverse split, it is looking mathematically at the market capitalization before and after the reverse split takes place, and concluding that if the market capitilization remains stable, the reduced share count should result in a higher price per share.

Looking at the OMED split history from start to finish, an original position size of 1000 shares would have turned into 200 today. Below, we examine the compound annual growth rate — CAGR for short — of an investment into OMED shares, starting with a $10,000 purchase of OMED, presented on a split-history-adjusted basis factoring in the complete OMED split history. OMED split adjusted history picture

Growth of $10,000.00
Without Dividends Reinvested

Start date: 04/21/2014
End date: 04/23/2019
Start price/share: $25.22
End price/share: $0.89
Dividends collected/share: $0.00
Total return: -96.47%
Average Annual Total Return: -48.71%
Starting investment: $10,000.00
Ending investment: $353.00
Years: 5.01
Date Ratio
08/16/19991 for 5
OMED is categorized under the Healthcare sector; below are some other companies in the same sector that also have a history of stock splits:

OMI Split History
ONCS Split History
ONCT Split History
ONCY Split History
ONTX Split History
ONTY Split History
ONVO Split History
OPCH Split History
OPGN Split History
OPTN Split History

Also explore: OMED shares outstanding history

Email EnvelopeFree OMED Email Alerts:
Get Dividend Alerts
Get SEC Filing Alerts

Golden Sun Health Technology Group Limited (GSUN)
Zapp Electric Vehicles Group Limited (ZAPP)
Beneficient (BENF)
MySize, Inc. (MYSZ)
Gorilla Technology Group Inc. (GRRR)
Sunshine Biopharma, Inc. (SBFM)
NFT Ltd. (MI)
WiSA Technologies, Inc. (WISA)
C3IS INC. (CISS)
Fluent, Inc. (FLNT)
More latest stock splits »
Latest mega mergers »
Latest stock buybacks »

OMED Insider Buying

OMED Split History | www.SplitHistory.com | Copyright © 2013 - 2024, All Rights Reserved

Nothing in www.SplitHistory.com is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. Split history database is not guaranteed to be complete or free of errors. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Service. Video widget and market videos powered by Market News Video. Quote and option data delayed at least 15 minutes; stock quote data powered by Ticker Technologies, and Mergent.
X
Wait! Don't leave yet.
Want to receive our latest research absolutely free?


Click the button below for your complimentary copy of Your Early Retirement Portfolio: Dividends Up to 8.7%—Every Month—Forever.

You'll discover the details on 4 stocks and funds that pay you massive dividends as high as 8.7%.